Back to results
US 7,919,467 B2Granted
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
AssigneeImmunotope, Inc.
InventorsVenky Ramakrishna, Mark M. Ross, Ramila Philip, Lorraine H. Keller
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
Claims14
A method for eliciting a CTL response against tumor cells presenting at least one of the following epitopic peptides:
- SEQ ID NO:
- 1516, 1517, 1519, 1521, 1527, 1528, or 1529 in a subject, comprising administering to said subject a composition comprising at least one polypeptide comprising an epitopic peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1516, 1517, 1519, 1521, 1527, 1528, and 1529 in an amount sufficient to induce a CTL response to said tumor cells.
Dependencies are inferred from the claim text.